Address
Other Office
21 Waterway Avenue,
Suite 225
The Woodlands, TX 77380
United States
Phone
Website
Recent investment activity
KANDO id: 30232
Corporate information
Registration country
Funding rounds
Top investment portfolio themes
Investment activity status
Active investor
Selected investments
Displaying 76 - 100 of 104Company | Profile | Country | Date | Funding | ||
---|---|---|---|---|---|---|
Velcera Inc | N/A | |||||
Victory Pharma Inc | Specialty pharmaceutical company | N/A | ||||
White Pine Medical | Targets medical device growth equity acquisitions | N/A | ||||
Xanodyne Pharmaceuticals Inc | Specialty pharmaceuticals for pain and women's health | N/A | ||||
Ziopharm Oncology Inc | Biopharmaceutical company engaged in the development and commercialization of a diverse, risk-sensitive portfolio of in-licensed cancer drugs. | N/A | ||||
Accumetrics Inc | Innovative developer and manufacturer of diagnostic instrumentation and test kits. | Venture | ||||
Accumetrics Inc | Innovative developer and manufacturer of diagnostic instrumentation and test kits. | Series E | ||||
Accumetrics Inc | Innovative developer and manufacturer of diagnostic instrumentation and test kits. | Series D | ||||
Accumetrics Inc | Innovative developer and manufacturer of diagnostic instrumentation and test kits. | Series C | ||||
Accumetrics Inc | Innovative developer and manufacturer of diagnostic instrumentation and test kits. | Series B | ||||
Active Day Inc | Provider of adult day health services in the United States. | N/A | ||||
Acura Pharmaceuticals | Pharmaceutical company | N/A | ||||
Allscripts Healthcare Solutions Inc | N/A | |||||
Arsenal Medical Inc | Biotechnology company focused on the development of therapeutic products based on its proprietary BioActive Composites platform. | N/A | ||||
BreatheAmerica Inc | N/A | |||||
Cell Therapeutics Inc | Biotherapeutics for cancer treatment. | N/A | ||||
Chroma Therapeutics Ltd | Focused on harnessing the power of chromatin biology and novel drug accumulation approaches to discover and develop a new generation of targeted cance | N/A | ||||
Complete Genomics Inc | Series E | |||||
Complete Genomics Inc | Series D | |||||
Entellus Medical Inc | Developer of innovative device technology and treatment to address the unmet needs of ENT physicians and their patients. | Series E | ||||
Entellus Medical Inc | Developer of innovative device technology and treatment to address the unmet needs of ENT physicians and their patients. | Series D | ||||
Kona Medical Inc | Developer of non-invasive treatment for hypertension | Series C | ||||
NeoVista Inc | Series E Follow-on investment | |||||
NeoVista Inc | Series D Follow-on investment | |||||
NeoVista Inc | Series C Initial investment |